Literature DB >> 6202804

Correlation between opsonic activity for various microorganisms and composition of gammaglobulin preparations for intravenous use.

R van Furth, P C Leijh, F Klein.   

Abstract

In this study 12 commercial immunoglobulin preparations for intravenous administration were investigated with respect to their opsonic activity for various strains of Staphylococcus aureus, Escherichia coli, Streptococcus pyogenes, and group B streptococci, and in addition, the concentration of unsplit IgG molecules, IgG fragments, and IgG aggregates (dimers) was determined. The results show that four preparations that had been treated with enzyme or by reduction and alkylation had hardly any opsonic activity; the other preparations were as effective as inactivated serum. A statistical analysis showed an excellent correlation between the concentration of intact IgG molecules in a preparation and the opsonic activity for the various bacteria; a negative correlation between the concentration of IgG fragments and the opsonic activity was found. The combination of the two techniques used in this study provides a basis for recommendations on the choice of gammaglobulin preparations for clinical use.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202804     DOI: 10.1093/infdis/149.4.511

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Multicenter crossover comparison of the safety and efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in patients with primary immunodeficiency diseases.

Authors:  R I Schiff; L W Williams; R P Nelson; R H Buckley; W Burks; R A Good
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

2.  Modulation of functional activity of human polymorphonuclear and mononuclear phagocytes by intravenous gamma globulin.

Authors:  W Pruzanski; S Saito
Journal:  Inflammation       Date:  1989-06       Impact factor: 4.092

3.  Haemophilus influenzae type b opsonins of intravenous immunoglobulins.

Authors:  S Bender; S Hetherington
Journal:  J Clin Immunol       Date:  1987-11       Impact factor: 8.317

4.  The capacity of various types of immunoglobulin for intravenous use to interact with Fc receptors of human monocytes and macrophages.

Authors:  T W Jungi; J Eiholzer; P G Lerch; S Barandun
Journal:  Blut       Date:  1986-10

5.  [Effect of Pseudomonas immunoglobulin on the antibacterial activity of human phagocytes].

Authors:  H M Just; M Termöhlen; M Pinkawa; F D Daschner
Journal:  Infection       Date:  1987       Impact factor: 3.553

6.  Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.

Authors:  N D Garbett; C S Munro; P J Cole
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

7.  Comparison of the clinical efficacy and safety of an intramuscular and an intravenous immunoglobulin preparation for replacement therapy in idiopathic adult onset panhypogammaglobulinaemia.

Authors:  N D Garbett; D C Currie; P J Cole
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

8.  Decreased protective efficacy of reduced and alkylated human immune serum globulin in experimental infection with Haemophilus influenzae type b.

Authors:  J R Schreiber; V A Barrus; G R Siber
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

9.  Opsonic activity in serum from septic infants treated with intravenous immunoglobulin.

Authors:  L Maródi; A Kalmár; I Szabó
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

10.  Antipyretic activity of a human immunoglobulin preparation for intravenous use in an experimental model of fever in rabbits.

Authors:  M Iwata; T Shimozato; H Tokiwa; E Tsubura
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.